Sallinen, H., Heikura, T., Koponen, J., Kosma, V., Heinonen, S., Ylä-Herttuala, S., & Anttila, M. (2014). Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer. BioMed Central.
Chicago ZitierstilSallinen, Hanna, Tommi Heikura, Jonna Koponen, Veli-Matti Kosma, Seppo Heinonen, Seppo Ylä-Herttuala, und Maarit Anttila. Serum Angiopoietin-2 and Soluble VEGFR-2 Levels Predict Malignancy of Ovarian Neoplasm and Poor Prognosis in Epithelial Ovarian Cancer. BioMed Central, 2014.
MLA ZitierstilSallinen, Hanna, et al. Serum Angiopoietin-2 and Soluble VEGFR-2 Levels Predict Malignancy of Ovarian Neoplasm and Poor Prognosis in Epithelial Ovarian Cancer. BioMed Central, 2014.